Порошок D-маннозы
Product Name:d-манноза
Grade:пищевой класс
Appearance:Белый порошок
Assay:99% d-mannose
Test:ВЭЖХ УФ
Place of Origin:Shaanxi,China
CAS No.:3458-28-4
Brand Name:Ширхерб
Active Ingredient:d-манноза
Sample:d-манноза Доступна
Storage:Прохладное сухое место
Shelf Life:2 years
Core Advantages of D-Mannose Powder:
- Прецизионная защита для здоровья мочевыводящих путей Targeted Anti-Adhesion: Competitively binds to the FimH flagella of Escherichia coli (with an affinity 50 times that of glucose), blocking bacterial adhesion to the urinary tract, with a bacterial clearance rate of over 90% within 24 hours Non-antibiotic mechanism: Does not kill bacteria, avoiding antibiotic resistance and disruption of the intestinal microbiota
- Метаболические преимущества и преимущества безопасности Smart Excretion: 85% of the original form is excreted via urine after oral administration, with local urinary system concentrations reaching 100 times that of blood Zero Glycemic Burden: Glycemic Index (GI) is only 2 (glucose is 100), safe for diabetic patients
- Технология синергетической рецептуры Cranberry synergistic effect: Proanthocyanidins inhibit bacterial biofilms, enhancing efficacy by 2 times Probiotic enhancement: Combined with Lactobacillus to reduce infection recurrence rate by 50%
- Удобство использования Instant micro powder: Dissolves in cold water in 3 seconds, with natural sweetness (50% of sucrose sweetness) Extreme safety: Acute toxicity LD50 > 10 g/kg, safe for use by pregnant women and children
Functional Effects of D-Mannose:
- ✅ Urinary Tract Infection (UTI) Management Acute episodes: 85% symptom relief rate within 48 hours Recurrence prevention: 1g/day taken before bedtime reduces annual recurrence rate from 5-6 times to 0-1 times
- ✅ Гинекологическое здоровье Adjuvant treatment for bacterial vaginosis, improvement of postmenopausal urinary syndrome.
- ✅ Послеоперационная защита. Reduces the risk of catheter-associated urinary tract infections by 70%, and reduces calcium oxalate crystals in urine by 25% in patients with kidney stones
- ✅ Кишечно-мочевая синергия Promotes the proliferation of bifidobacteria , inhibits the migration of pathogenic bacteria, and reduces endotoxin entry into the bloodstream。




